Laurus Labs Limited has informed the Exchange about Approval of Scheme of Arrangement
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laurus Labs' Board has approved a Composite Scheme of Arrangement to reorganize its wholly owned subsidiary Laurus Synthesis Pvt Ltd (LSPL). Under the scheme, Unit-1 of LSPL (CDMO/CRAMS business) will be demerged and merged into Sriam Labs Pvt Ltd (API manufacturing), while the remaining business of LSPL will be amalgamated back into Laurus Labs and LSPL will be dissolved. The appointed date is April 1, 2026, subject to NCLT approval. As consideration for the demerger, Sriam Labs will issue 27 equity shares (₹10 each) to Laurus Labs for every 1 share held in LSPL. For the amalgamation of remaining LSPL into Laurus Labs, no new shares will be issued since LSPL is wholly owned, so there is no change in Laurus Labs' shareholding pattern. The rationale is consolidation of similar businesses, simplification of group structure, and operational efficiencies.
This is an internal group restructuring among wholly owned subsidiaries and should be largely neutral for Laurus Labs shareholders — no dilution, no cash outflow, and no change in shareholding. The reorganization may improve operational efficiency and business focus, but the actual effect on the stock is expected to be minimal unless execution reveals unexpected synergies or costs.